Summit Midstream Partners LP (SMLP):企業の財務・戦略的SWOT分析

◆英語タイトル:Summit Midstream Partners LP (SMLP) - Financial and Strategic SWOT Analysis Review
◆商品コード:GDGE477983FSA
◆発行会社(調査会社):GlobalData
◆発行日:2021年4月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:Oil and Gas
◆販売価格オプション(消費税別)
Site License(同一事業所内共有可)USD600 ⇒換算¥84,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥126,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Summit Midstream Partners LP (SMLP) is an oil and gas company that develops, owns and operates midstream energy infrastructure assets located in unconventional shale resource basins and shale formations across North America. The company operates natural gas, crude oil, and produced water gathering systems in unconventional resource basins including Williston Basin, Fort Worth Basin, Appalachian Basin, Delaware Basin, Piceance Basin and Denver-Julesburg Basin. It also develops natural gas gathering and condensate stabilization infrastructure in the Utica Shale in southeastern Ohio. SMLP’s Appalachian Basin includes the Marcellus and Utica shale formations in West Virginia and Ohio. The company’s Denver-Julesburg Basin comprises of the Niobrara and Codell shale formations in Colorado and Wyoming. It has operations in Texas, Georgia and Colorado, the US. SMLP is headquartered in The Woodlands, Texas, the US.

Summit Midstream Partners LP Key Recent Developments

Mar 08,2021: Summit Midstream Partners announces closing of financing for the Double E Pipeline Project
Mar 04,2021: Summit Midstream Partners, LP Reports Fourth Quarter 2020 Financial and Operating Results and Confirms 2021 Financial Guidance
Feb 02,2021: Summit Midstream Partners, LP Announces $175 million of Financing Commitments for its Double E Pipeline Project and Schedules Fourth Quarter 2020 Earnings Call
Jan 13,2021: Double E’s 1.35 Bcf/d natural gas project from Permian to Gulf Coast OK’d for construction

This comprehensive SWOT profile of Summit Midstream Partners LP provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Summit Midstream Partners LP including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Summit Midstream Partners LP – Key Information
Summit Midstream Partners LP – Overview
Summit Midstream Partners LP – Key Employees
Summit Midstream Partners LP – Key Employee Biographies
Summit Midstream Partners LP – Key Operational Heads
Summit Midstream Partners LP – Major Products and Services
Summit Midstream Partners LP – History
Summit Midstream Partners LP – Company Statement
Summit Midstream Partners LP – Locations And Subsidiaries

Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Summit Midstream Partners LP – Business Description
Summit Midstream Partners LP – Corporate Strategy
Summit Midstream Partners LP – SWOT Analysis
SWOT Analysis – Overview
Summit Midstream Partners LP – Strengths
Summit Midstream Partners LP – Weaknesses
Summit Midstream Partners LP – Opportunities
Summit Midstream Partners LP – Threats
Summit Midstream Partners LP – Key Competitors

Section 3 – Company Financial Performance Charts

Summit Midstream Partners LP – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Summit Midstream Partners LP, Key Information
Summit Midstream Partners LP, Key Ratios
Summit Midstream Partners LP, Share Data
Summit Midstream Partners LP, Major Products and Services
Summit Midstream Partners LP, History
Summit Midstream Partners LP, Key Employees
Summit Midstream Partners LP, Key Employee Biographies
Summit Midstream Partners LP, Key Operational Heads
Summit Midstream Partners LP, Other Locations
Summit Midstream Partners LP, Subsidiaries

Summit Midstream Partners LP, Key Competitors
Summit Midstream Partners LP, SWOT Analysis
Summit Midstream Partners LP, Ratios based on current share price
Summit Midstream Partners LP, Annual Ratios
Summit Midstream Partners LP, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

★海外企業調査レポート[Summit Midstream Partners LP (SMLP):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Abengoa, S.A.:企業の戦略・SWOT・財務情報
    Abengoa, S.A. - Strategy, SWOT and Corporate Finance Report Summary Abengoa, S.A. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Ageas NV:企業の戦略・SWOT・財務情報
    Ageas NV - Strategy, SWOT and Corporate Finance Report Summary Ageas NV - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, …
  • Oil Refineries Ltd (ORL):企業の財務・戦略的SWOT分析
    Oil Refineries Ltd (ORL) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • Yeda Research and Development Company Ltd-製薬・医療分野:企業M&A・提携分析
    Summary Yeda Research and Development Company Ltd (Yeda), a subsidiary of Weizmann Institute of Science is a technology transfer company that provides research and science education. The company identifies and assesses research projects with commercial potential, protects the intellectual property o …
  • TesoRx Pharma LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary TesoRx Pharma LLC (TesoRx) is a pharmaceutical company that develops treatments to address unmet medical needs. The company’s product pipeline comprises TSD-001, TSD-005, TSX-011 and TSX-002. Its TSD-001is an intravesical paclitaxel for the treatment of non-muscle invasive bladder cancer. Te …
  • 3D Systems Corporation:企業の戦略・SWOT・財務分析
    3D Systems Corporation - Strategy, SWOT and Corporate Finance Report Summary 3D Systems Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offer …
  • Parenteral Drug India Ltd (PDPL):企業の財務・戦略的SWOT分析
    Summary Parenteral Drug India Ltd (PDIL) is a healthcare company that manufactures pharmaceutical products. The company provides products such as solid and liquid orals, IV fluids, oncology products and anaesthesia products. It offers IV fluids such as carbohyrated and electrolytes; diuretics, dialy …
  • PayPoint plc:企業の戦略・SWOT・財務分析
    PayPoint plc - Strategy, SWOT and Corporate Finance Report Summary PayPoint plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate a …
  • Innogy SE (IGY):電力:M&Aディール及び事業提携情報
    Summary Innogy SE (Innogy), a subsidiary of RWE AG, is an energy company. The company offers electricity and natural gas. It operates through its business segments such as renewables, grid and infrastructure, and retail. Innogy’s company’s grid and infrastructure segment operates electricity and gas …
  • Paddy Power Betfair Plc
    Paddy Power Betfair Plc - Strategy, SWOT and Corporate Finance Report Summary Paddy Power Betfair Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Central Iowa Power Cooperative:企業の戦略的SWOT分析
    Central Iowa Power Cooperative - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Biotron Ltd (BIT):製薬・医療:M&Aディール及び事業提携情報
    Summary Biotron Ltd (Biotron) is a clinical stage biotechnology company which researches, develops and commercializes small molecules for the treatment of infectious diseases. Biotron’s core focus is to design and develop drugs that target viral ion channel proteins (viroporins). The company’s lead …
  • Mediq NV:企業の戦略的SWOT分析
    Mediq NV - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. Thi …
  • Novo Nordisk AS (NOVO B)-医療機器分野:企業M&A・提携分析
    Summary Novo Nordisk A/S (Novo Nordisk), a subsidiary of Novo A/S discovers, develops and manufactures innovative biological medicines. It focuses at developing drugs for treating diabetes and other serious chronic conditions including hemophilia, growth disorders and obesity. The company’s product …
  • Public Gas Corporation SA:企業の戦略的SWOT分析
    Public Gas Corporation SA - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • Credit Du Nord Sa:企業の戦略・SWOT・財務分析
    Credit Du Nord Sa - Strategy, SWOT and Corporate Finance Report Summary Credit Du Nord Sa - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and c …
  • Meiji Holdings Co, Ltd.
    Meiji Holdings Co, Ltd. - Strategy, SWOT and Corporate Finance Report Summary Meiji Holdings Co, Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • OncoSec Medical Inc (ONCS):企業の財務・戦略的SWOT分析
    Summary OncoSec Medical Inc (OncoSec) is a biotechnology company. The company offers services to stimulate body’s immune system and attack cancer. Its lead candidate, ImmunoPulse IL-12, consists of a plasmid construct encoding the proinflammatory cytokine, IL-12, which is delivered into the tumor th …
  • Fiskars Corporation:企業の戦略・SWOT・財務情報
    Fiskars Corporation - Strategy, SWOT and Corporate Finance Report Summary Fiskars Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Symantec Corporation:企業の戦略・SWOT・財務情報
    Symantec Corporation - Strategy, SWOT and Corporate Finance Report Summary Symantec Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆